Squadron Capital

Squadron Capital seeks to acquire and invest in operating companies located both in the US and abroad. Squadron is not a traditional private equity firm but an acquisition vehicle funded by a Chicago-based trust and led from its headquarters near Hartford, Connecticut. Squadron is exceptionally well-capitalized and typically does not require any debt financing. These resources allow us to move quickly through our diligence process to closing. Typical companies of interest have revenues in the range of $10 to $100 million. We are currently seeking an offshore acquisition. Their mission is long-term investment (multi-generational) and assistance to the portfolio companies’ leadership teams in the execution of their business plans. Squadron’s governance/oversight structure is highly decentralized and offers a unique opportunity for a company’s leadership to grow and lead “their” company.

David Pelizzon

President and Founder

4 past transactions

Peak Nano Optics

Venture Round in 2021
Developer of nanotechnology products. The company's nanolayer gradient refractive index (GRIN) technology allows for the design and manufacture of lenses with greater electro-optical performance in visible to near-infrared applications at a fraction of the size, weight and volume of currently available complex lenses, enabling medical and commercial sectors to create desired spherical refractive index distributions within the lens.

OsteoCentric Technologies

Venture Round in 2021
OsteoCentric Technologies is an IT company that designs and develops unifi mechanical integration technology for healthcare surgeons.

Peak Nano Optics

Series C in 2020
Developer of nanotechnology products. The company's nanolayer gradient refractive index (GRIN) technology allows for the design and manufacture of lenses with greater electro-optical performance in visible to near-infrared applications at a fraction of the size, weight and volume of currently available complex lenses, enabling medical and commercial sectors to create desired spherical refractive index distributions within the lens.

Forum Plastics

Acquisition in 2016
Forum Plastics Inc. is a precision medical mold developer and molder of engineered thermoplastics, insert molding and elastomers. Their operations run across three shifts, twenty-four hours.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.